ZIM Laboratories has completed an equity investment of €3,00,000 in its wholly owned subsidiary, SIA ZIM Laboratories, maintaining 100% ownership.

This capital infusion likely supports operational expansion or strengthens the subsidiary's business prospects, reinforcing ZIM's control and commitment to its international operations without diluting ownership.

No change in stake or immediate financial impact on the parent’s consolidated numbers is indicated.